Nobiletin inhibits hypoxia-induced epithelial-mesenchymal transition in renal cell carcinoma cells.
epithelial-mesenchymal transition (EMT)
hypoxia
nobiletin
renal cell carcinoma (RCC)
Journal
Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
09
05
2018
accepted:
25
07
2018
pubmed:
12
9
2018
medline:
12
9
2018
entrez:
12
9
2018
Statut:
ppublish
Résumé
Hypoxia is a universal characteristic of solid tumor and involving cancer metastasis via epithelial-mesenchymal transition (EMT). Nobiletin (3',4',5,6,7,8-hexamethoxyflavone), a dietary polymethoxylated flavonoid found in citrus fruits, has been reported to have anticancer effects. However, the possible role of nobiletin in renal cell carcinoma (RCC) remains unclear. Thus, the aim of this study was to identify the effect of nobiletin on hypoxia-induced EMT in RCC cells. We found that nobiletin significantly inhibited the migration and invasion induced by hypoxia in RCC cells. In addition, nobiletin reversed the hypoxia-induced EMT process in RCC cells. Furthermore, nobiletin suppressed the activation of NF-κB and Wnt/β-catenin signaling pathways in hypoxia-stimulated RCC cells. In conclusion, these findings demonstrate that nobiletin inhibits hypoxia-induced EMT in human RCC cells via the inactivation of the NF-κB and Wnt/β-catenin signaling pathways.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2039-2046Informations de copyright
© 2018 Wiley Periodicals, Inc.